SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001140361-20-029928
Filing Date
2020-12-30
Accepted
2020-12-30 17:13:10
Documents
4
Period of Report
2020-11-05
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A brhc10018438_8ka.htm 8-K/A 43459
2 EXHIBIT 23.1 brhc10018438_ex23-1.htm EX-23.1 1927
3 EXHIBIT 99.3 brhc10018438_ex99-3.htm EX-99.3 489801
4 EXHIBIT 99.4 brhc10018438_ex99-4.htm EX-99.4 339851
  Complete submission text file 0001140361-20-029928.txt   876345
Mailing Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335
Business Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335 248-681-9815
Ocuphire Pharma, Inc. (Filer) CIK: 0001228627 (see all company filings)

IRS No.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-34079 | Film No.: 201426608
SIC: 2834 Pharmaceutical Preparations